The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Synergistic effects of low-dose belantamab mafodotin in combination with a gamma-secretase inhibitor (nirogacestat) in patients with relapsed/refractory multiple myeloma (RRMM): DREAMM-5 study.
 
Sagar Lonial
Stock and Other Ownership Interests - TG Therapeutics
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Novartis; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
Other Relationship - TG Therapeutics
 
Sebastian Grosicki
No Relationships to Disclose
 
Marek Hus
No Relationships to Disclose
 
Kevin W. Song
Honoraria - Amgen; Bristol-Myers Squibb/Celgene; Janssen; Sanofi
Consulting or Advisory Role - Amgen; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Sanofi
 
Thierry Facon
Consulting or Advisory Role - Lille University Hospital (Inst)
Speakers' Bureau - Lille University Hospital (Inst)
 
Natalie Scott Callander
Research Funding - Cellectar
 
Vincent Ribrag
Honoraria - Abbvie; AZD; Gilead Sciences; Infinity Pharmaceuticals; NanoString Technologies; Novartis; roche
Consulting or Advisory Role - Bristol-Myers Squibb; Gilead Sciences; Immune Design; Incyte; Infinity Pharmaceuticals; MSD; NanoString Technologies; PharmaMar; Roche; Roche/Genentech
Research Funding - arGEN-X BVBA; argenx (Inst); Astex Pharmaceuticals (Inst); Epizyme (Inst); GlaxoSmithKline/Adaptimmune (Inst)
Expert Testimony - SERVIER
Travel, Accommodations, Expenses - azd; AZD; Bristol-Myers Squibb; Bristol-Myers Squibb; Roche
 
Katarina Uttervall
No Relationships to Disclose
 
HANG QUACH
Consulting or Advisory Role - Amgen; Antengene; Celgene; CSL Behring; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Sanofi
Research Funding - Amgen; Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
 
Vladimir I. Vorobyev
Honoraria - Abbvie; Amgen; AstraZeneca; BeiGene; Gilead Sciences; Janssen; Novartis; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Gilead Sciences; Janssen Oncology; Novartis; Roche; Sanofi; Takeda
Speakers' Bureau - Abbvie; Amgen; AstraZeneca; BeiGene; BioCad; BMSi; Janssen; MSD; Novartis; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca
 
Chang Ki Min
No Relationships to Disclose
 
Shinta Cheng
Employment - Janssen Research & Development; SpringWorks Therapeutics
Stock and Other Ownership Interests - SpringWorks Therapeutics
 
L. Mary Smith
Employment - SpringWorks Therapeutics
Leadership - SpringWorks Therapeutics
Stock and Other Ownership Interests - SpringWorks Therapeutics
 
Jing Yu
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Therese Collingwood
No Relationships to Disclose
 
Beata Holkova
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - GlaxoSmithKline (Inst)
 
Brandon Kremer
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Ira Gupta
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Secura Bio; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Monique C. Minnema
Consulting or Advisory Role - Janssen-Cilag (Inst)
Speakers' Bureau - Celgene/Bristol-Myers Squibb (Inst); Janssen medical Affairs (Inst); Medscape (Inst)